Literature DB >> 33176253

Phages to shape the gut microbiota?

Sofia Dahlman1, Laura Avellaneda-Franco1, Jeremy J Barr2.   

Abstract

The concept of (bacterio)phage therapy is simple; target the phage to the bacterial pathogen causing disease. As phages are natural killers of bacteria, one could expect this to be an easy task. However, when it comes to phage therapy within the gut, it might not be quite that simple. Already without exogenous intervention, a multitude of phage-bacterial interactions occur within the human gut, some of which might play a direct role in disease progression. In this perspective, we aim to summarise the current understanding of phages within our gut, moving from infancy, adulthood, and then into disease progression. We then highlight recent advances in phage-based interventions, both conventional phage therapy and the progressing field of whole virome transplant.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 33176253     DOI: 10.1016/j.copbio.2020.09.016

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  10 in total

Review 1.  Disentangling host-microbiota complexity through hologenomics.

Authors:  Antton Alberdi; Sandra B Andersen; Morten T Limborg; Robert R Dunn; M Thomas P Gilbert
Journal:  Nat Rev Genet       Date:  2021-10-21       Impact factor: 53.242

2.  The Gut Microbiota of Healthy and Flavobacterium psychrophilum-Infected Rainbow Trout Fry Is Shaped by Antibiotics and Phage Therapies.

Authors:  Valentina Laura Donati; Lone Madsen; Mathias Middelboe; Mikael Lenz Strube; Inger Dalsgaard
Journal:  Front Microbiol       Date:  2022-05-10       Impact factor: 6.064

Review 3.  Ischemic stroke and intestinal flora: an insight into brain-gut axis.

Authors:  Wenjie Hu; Xiangyi Kong; Hui Wang; Yunqing Li; Yimin Luo
Journal:  Eur J Med Res       Date:  2022-05-25       Impact factor: 4.981

4.  Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.

Authors:  Małgorzata Łobocka; Krystyna Dąbrowska; Andrzej Górski
Journal:  BioDrugs       Date:  2021-04-21       Impact factor: 5.807

5.  Isolation and Characterization of the Lytic Pseudoxanthomonas kaohsiungensi Phage PW916.

Authors:  Chang Wen; Chaofan Ai; Shiyun Lu; Qiue Yang; Hanpeng Liao; Shungui Zhou
Journal:  Viruses       Date:  2022-08-02       Impact factor: 5.818

6.  Phage-prokaryote coexistence strategy mediates microbial community diversity in the intestine and sediment microhabitats of shrimp culture pond ecosystem.

Authors:  Zhixuan Deng; Shenzheng Zeng; Renjun Zhou; Dongwei Hou; Shicheng Bao; Linyu Zhang; Qilu Hou; Xuanting Li; Shaoping Weng; Jianguo He; Zhijian Huang
Journal:  Front Microbiol       Date:  2022-09-23       Impact factor: 6.064

Review 7.  Interactions between bacterial and phage communities in natural environments.

Authors:  Anne Chevallereau; Benoît J Pons; Stineke van Houte; Edze R Westra
Journal:  Nat Rev Microbiol       Date:  2021-08-09       Impact factor: 60.633

Review 8.  The Gut-Liver Axis in Cholestatic Liver Diseases.

Authors:  Andreas Blesl; Vanessa Stadlbauer
Journal:  Nutrients       Date:  2021-03-21       Impact factor: 5.717

Review 9.  Treating Bacterial Infections with Bacteriophage-Based Enzybiotics: In Vitro, In Vivo and Clinical Application.

Authors:  Katarzyna M Danis-Wlodarczyk; Daniel J Wozniak; Stephen T Abedon
Journal:  Antibiotics (Basel)       Date:  2021-12-06

10.  Roles for non-human primate-associated phage diversity in improving medicine and public health.

Authors:  Jan F Gogarten
Journal:  Evol Med Public Health       Date:  2022-02-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.